The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain.
The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV ...
ScienceAlert on MSN
HIV's Cunning Strategy For Hiding in Our Body Finally Revealed
According to the new study, HIV achieves this with a tissue-specific approach, cloaking itself in a host cell's DNA by ...
The challenge with curing the Human Immunodeficiency Virus (HIV) is that it tends to hide dormant in cells, evading the ...
Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.
ZME Science on MSN
Scientists Discover Antibody that Blocks 98% of HIV Strains
The antibody, called 04_A06, blocked 98.5% of more than 300 different HIV strains in lab tests, including many resistant to ...
Newspoint on MSN
HIV AIDS: How the risk of HIV increases, understand stage by stage how dangerous its symptoms become.
If someone becomes infected with HIV and does not seek timely treatment, the infection gradually progresses through three stages. Each stage has different symptoms and risks. HIV AIDS: If a person ...
One in ten clinics in South Africa — across 22 health districts in six provinces — will start to hand out a twice-a-year anti ...
One in 10 clinics in SA — across 22 health districts in six provinces — could start to hand out a twice-a-year anti-HIV jab ...
NanoViricides, Inc., a publicly traded company (NYSE Amer:NNVC) (the "Company"), announced that its clinical lead drug NV-387 ...
One in 10 clinics in South Africa will start to hand out a twice-a-year anti-HIV jab as early as February. The country’s medicines regulator, Sahpra, says it’s on track to announce its registration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback